Overview: In May 2020 United Kingdom's Special Pharmaceuticals exports accounted up to £21.3M and imports accounted up to £32.2M, resulting in a negative trade balance of £10.9M. Between May 2019 and May 2020 the exports of United Kingdom's Special Pharmaceuticals have decreased by £-8.65M (-28.8%) from £30M to £21.3M, while imports decreased by £-8.25M (-20.4%) from £40.4M to £32.2M.
Destinations: In May 2020 Special Pharmaceuticals exported mostly to France (£4.45M), United States (£2.84M), Australia (£1.74M), Germany (£1.57M), and Canada (£1.24M), and imported mostly from Netherlands (£8.25M), Hungary (£8.04M), Germany (£2.39M), Belgium (£2.33M), and France (£2.24M).
Growth: In May 2020, the decrease in Special Pharmaceuticals's year-by-year exports was explained primarily by a decrease in exports to United States (£-4.47M or -61.1%), Australia (£-1.36M or -43.8%), and Germany (£-886k or -36.1%). In May 2020, the decrease in Special Pharmaceuticals's year-by-year imports was explained primarily by a decrease in imports from Hungary (£-3.66M or -31.2%), Belgium (£-3.5M or -60.1%), and Germany (£-1.66M or -41%).